| Autor: |
Charles E. Murry, Ty Higashi, Nathan J. Sniadecki, Silvia Marchianò, Akshita Khanna, Alessandro Bertero, Hans Reinecke, Michael Gale, Xiulan Yang, Tien-Ying Hsiang, Lil Pabon |
| Rok vydání: |
2020 |
| Předmět: |
|
| DOI: |
10.1101/2020.08.30.274464 |
| Popis: |
Global health has been threatened by the COVID-19 pandemic, caused by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2)1. Although considered primarily a respiratory infection, many COVID-19 patients also suffer severe cardiovascular disease2–4. Improving patient care critically relies on understanding if cardiovascular pathology is caused directly by viral infection of cardiac cells or indirectly via systemic inflammation and/or coagulation abnormalities3,5–9. Here we examine the cardiac tropism of SARS-CoV-2 using human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) and three-dimensional engineered heart tissues (3D-EHTs). We observe that hPSC-CMs express the viral receptor ACE2 and other viral processing factors, and that SARS-CoV-2 readily infects and replicates within hPSC-CMs, resulting in rapid cell death. Moreover, infected hPSC-CMs show a progressive impairment in both electrophysiological and contractile properties. Thus, COVID-19-related cardiac symptoms likely result from a direct cardiotoxic effect of SARS-CoV-2. Long-term cardiac complications might be possible sequelae in patients who recover from this illness. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
